Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Blanchette

Showing results (31-40 of 117) with videos related to

Pageof 12
Sort By:
Clinical Therapeutics|January 30, 2010
Association between previous health care use and initiation of inhaled corticosteroid and long-acting beta2-adrenergic agonist combination therapy among US patients with asthmaChristopher M Blanchette, Steven D Culler, Daniel Ershoff, et al.
The Journal of Otolaryngology|October 1, 1981
Serous otitis media: a six week prospective studyA Lamothe, V Boudreault, M Blanchette, et al.
Drugs in Context|January 17, 2014
Probabilistic data linkage: a case study of comparative effectiveness in COPDChristopher M Blanchette, Mitch Dekoven, Ajita P De, et al.
The Journal of Biological Chemistry|March 30, 2001
Dimethyl sulfoxide affects the selection of splice sitesL Bolduc, B Labrecque, M Cordeau, et al.
The American Journal of Geriatric Pharmacotherapy|September 9, 2008
Risk of hospitalizations/emergency department visits and treatment costs associated with initial maintenance therapy using fluticasone propionate 500 microg/salmeterol 50 microg compared with ipratropium for chronic obstructive pulmonary disease in older adultsChristopher M Blanchette, Manabu Akazawa, Anand Dalal, et al.
The Journal of Cell Biology|December 12, 2001
The Tlg SNARE complex is required for TGN homotypic fusionJ H Brickner, J M Blanchette, G Sipos, et al.
Journal of Medical Economics|October 16, 2009
Healthcare costs associated with initial maintenance therapy with fluticasone propionate 250 μg/salmeterol 50 μg combination versus anticholinergic bronchodilators in elderly US Medicare-eligible beneficiaries with COPDAnand A Dalal, Hans Petersen, Linda Simoni-Wastila, et al.
The American Journal of Managed Care|July 10, 2008
Economic assessment of initial maintenance therapy for chronic obstructive pulmonary diseaseManabu Akazawa, D Courtney Hayflinger, Richard H Stanford, et al.
Current Medical Research and Opinion|July 23, 2009
Appropriate use of inhaled corticosteroid and long-acting beta(2)-adrenergic agonist combination therapy among asthma patients in a US commercially insured populationXin Ye, Benjamin Gutierrez, Victoria Zarotsky, et al.
Annals of Epidemiology|February 12, 2008
A secondary analysis of a duration response association between selective serotonin reuptake inhibitor use and the risk of acute myocardial infarction in the aging populationChristopher M Blanchette, Linda Simoni-Wastila, Ilene H Zuckerman, et al.
Pageof 12

Showing results (31-40 of 117) with videos related to

Sort By:
Pageof 12
Clinical Therapeutics|January 30, 2010
Association between previous health care use and initiation of inhaled corticosteroid and long-acting beta2-adrenergic agonist combination therapy among US patients with asthmaChristopher M Blanchette, Steven D Culler, Daniel Ershoff, et al.
The Journal of Otolaryngology|October 1, 1981
Serous otitis media: a six week prospective studyA Lamothe, V Boudreault, M Blanchette, et al.
Drugs in Context|January 17, 2014
Probabilistic data linkage: a case study of comparative effectiveness in COPDChristopher M Blanchette, Mitch Dekoven, Ajita P De, et al.
The Journal of Biological Chemistry|March 30, 2001
Dimethyl sulfoxide affects the selection of splice sitesL Bolduc, B Labrecque, M Cordeau, et al.
The American Journal of Geriatric Pharmacotherapy|September 9, 2008
Risk of hospitalizations/emergency department visits and treatment costs associated with initial maintenance therapy using fluticasone propionate 500 microg/salmeterol 50 microg compared with ipratropium for chronic obstructive pulmonary disease in older adultsChristopher M Blanchette, Manabu Akazawa, Anand Dalal, et al.
The Journal of Cell Biology|December 12, 2001
The Tlg SNARE complex is required for TGN homotypic fusionJ H Brickner, J M Blanchette, G Sipos, et al.
Journal of Medical Economics|October 16, 2009
Healthcare costs associated with initial maintenance therapy with fluticasone propionate 250 μg/salmeterol 50 μg combination versus anticholinergic bronchodilators in elderly US Medicare-eligible beneficiaries with COPDAnand A Dalal, Hans Petersen, Linda Simoni-Wastila, et al.
The American Journal of Managed Care|July 10, 2008
Economic assessment of initial maintenance therapy for chronic obstructive pulmonary diseaseManabu Akazawa, D Courtney Hayflinger, Richard H Stanford, et al.
Current Medical Research and Opinion|July 23, 2009
Appropriate use of inhaled corticosteroid and long-acting beta(2)-adrenergic agonist combination therapy among asthma patients in a US commercially insured populationXin Ye, Benjamin Gutierrez, Victoria Zarotsky, et al.
Annals of Epidemiology|February 12, 2008
A secondary analysis of a duration response association between selective serotonin reuptake inhibitor use and the risk of acute myocardial infarction in the aging populationChristopher M Blanchette, Linda Simoni-Wastila, Ilene H Zuckerman, et al.
Pageof 12